Global Cancer Therapies Industry

  • October 2011
  • -
  • Global Industry Analysts

Summary

Table of Contents

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The report profiles 152 companies including many key and niche players such as Amgen, Inc., AstraZeneca PLC, Bayer Schering Pharma, Biogen Idec Inc., Bristol-Myers Squibb Company, Celgene Corporation, Cell Therapeutics, Inc., Cephalon, Inc., Chugai Pharmaceutical Co., Ltd., Eli Lilly and Company, Imclone Systems, Inc., F. Hoffmann-La Roche Ltd., Genentech, Inc., Genzyme, GlaxoSmithKline, Janssen Biotech, Inc., Merck KGaA, Novartis AG, OSI Pharmaceuticals, Inc., Pfizer, Sanofi-Aventis, Seattle Genetics, Inc., and Takeda Pharmaceutical Company Limited. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

Get This Report

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape

  • $ 6 000
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy ...

The Market for Personalized Gene Therapy Treatments for Cancer

The Market for Personalized Gene Therapy Treatments for Cancer

  • $ 3 995
  • Industry report
  • December 2014
  • by Kalorama Information

This report, The Market for Personalized Gene Therapy Treatments For Cancer provides an exhaustive review of the market potential for relatively new approach in cancer research. It involves modification ...

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

Gene Therapy Oncology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape

  • $ 3 500
  • Industry report
  • January 2015
  • by Delve Insight

Summary DelveInsight's Report: Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.